SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001509190-15-000005
Filing Date
2015-03-16
Accepted
2015-03-16 17:24:13
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K petx-20141231x10k.htm 10-K 5198655
2 EX-21.1 petx-20141231ex211749666.htm EX-21.1 7307
3 EX-23.1 petx-20141231ex2312df434.htm EX-23.1 2818
4 EX-31.1 petx-20141231ex3110f6d21.htm EX-31.1 20325
5 EX-31.2 petx-20141231ex312808009.htm EX-31.2 20619
6 EX-32.1 petx-20141231ex321575000.htm EX-32.1 7079
7 EX-32.2 petx-20141231ex322b5654e.htm EX-32.2 7682
8 GRAPHIC petx-20141231x10kg001.jpg GRAPHIC 70765
  Complete submission text file 0001509190-15-000005.txt   28720165

Data Files

Seq Description Document Type Size
9 EX-101.INS petx-20141231.xml EX-101.INS 4934179
10 EX-101.SCH petx-20141231.xsd EX-101.SCH 95930
11 EX-101.CAL petx-20141231_cal.xml EX-101.CAL 108983
12 EX-101.DEF petx-20141231_def.xml EX-101.DEF 564438
13 EX-101.LAB petx-20141231_lab.xml EX-101.LAB 745399
14 EX-101.PRE petx-20141231_pre.xml EX-101.PRE 893128
Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35952 | Film No.: 15704091
SIC: 2834 Pharmaceutical Preparations